In one paragraphArticle in Research square, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed, 0 citations in OpenAlex.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
5 · Who and what moneyAuthors and funding
17 authors at 2 institutions in 1 country.
Sydney AlderferBuck Institute for Research on Aging, Novato, CA 94947, USA.
Eric B DammerEmory Center for Neurodegenerative Disease, Emory University School of Medicine, Atlanta, GA 30322, USA.
Enrique M CarreraBuck Institute for Research on Aging, Novato, CA 94947, USA.
Jackson H ChenBuck Institute for Research on Aging, Novato, CA 94947, USA.
Grant KauweBuck Institute for Research on Aging, Novato, CA 94947, USA.
Tara E TracyBuck Institute for Research on Aging, Novato, CA 94947, USA.
Lisa M EllerbyBuck Institute for Research on Aging, Novato, CA 94947, USA.
Buck Institute for Research on Aging · USEmory University · US
Funding
Smartphone-Based "Burst" Cognitive AssessmentsP01AG003991 · NIA · WASHINGTON UNIVERSITY · PI JOHN MORRIS · 1985 to 2026
$69.5MThe natural history of AB accumulation in preclinical ADP01AG026276 · NIA · WASHINGTON UNIVERSITY · PI MORRIS, JOHN · 2005 to 2025
$49.5MResearch Education ComponentP30AG066444 · NIA · WASHINGTON UNIVERSITY · PI Susan Lynn Stark · 2020 to 2026
$28.7MSingle cell analysis coreP01AG066591 · NIA · BUCK INSTITUTE FOR RESEARCH ON AGING · PI MELOV, SIMON · 2021 to 2025
$15.5MTraining in Basic Research on Aging and Age-Related DiseaseT32AG000266 · NIA · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI Lisa M Ellerby · 1998 to 2026
$13.8MResilience pathways modeling human longevity-promoting ApoE variants in induced pluripotent stem cellsR01AG061879 · NIA · BUCK INSTITUTE FOR RESEARCH ON AGING · PI ELLERBY, LISA M, MELOV, SIMON · 2018 to 2022
$4.4MImpaired activity-dependent protein synthesis in dendrites and pathophysiology in tauopathyR01AG070193 · NIA · BUCK INSTITUTE FOR RESEARCH ON AGING · PI TRACY, TARA · 2021 to 2025
$3.9MMolecular Mechanisms of Lifespan Extension by Dietary Restriction in DrosophilaR01AG038688 · NIA · BUCK INSTITUTE FOR RESEARCH ON AGING · PI KAPAHI, PANKAJ · 2011 to 2015
$2.3MRole of Circadian Clocks in Aging using DrosophilaR01AG045835 · NIA · BUCK INSTITUTE FOR RESEARCH ON AGING · PI KAPAHI, PANKAJ · 2013 to 2017
$2.1MThe role of natural genetic variants in nutrient-dependent changes in healthspan using D. melanogasterR21AG054121 · NIA · BUCK INSTITUTE FOR RESEARCH ON AGING · PI BREM, RACHEL BETH, KAPAHI, PANKAJ · 2017 to 2018
$825kTripleTOF 5600 High Resolution Mass SpectrometerS10OD016281 · OD · BUCK INSTITUTE FOR RESEARCH ON AGING · PI GIBSON, BRADFORD WAYNE · 2013 to 2013
$597kGENETIC DISRUPTION OF TAU METABOLISM IN TAUOPATHIESK01AG046374 · NIA · WASHINGTON UNIVERSITY · PI KARCH, CELESTE MARIE · 2014 to 2018
$568kNIA NIH HHS K01 AG046374NIA NIH HHS P01 AG003991NIA NIH HHS P01 AG026276NIA NIH HHS P01 AG066591NIA NIH HHS P30 AG066444NIA NIH HHS R01 AG038688NIA NIH HHS R01 AG045835NIA NIH HHS R01 AG061879NIA NIH HHS R01 AG070193NIA NIH HHS R21 AG054121NIA NIH HHS T32 AG000266NIH HHS S10 OD016281
6 · The paper itselfAbstract
Tauopathies encompass a range of neurodegenerative disorders, such as Alzheimer's disease (AD) and frontotemporal dementia (FTD). Unfortunately, current treatment approaches for tauopathies have yielded limited success, underscoring the pressing need for novel therapeutic strategies. We observed distinct signatures of impaired glycogen metabolism in the
Identifiers
PMID37986935
PMCPMC10659530
OpenAlexW4388478426
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390